Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Adding Sofosbuvir/Ledipasvir Combination, or Nitazoxanide to the Standard of Care in Treatment of COVID-19: A Randomized Controlled Trial

NCT04498936 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04498936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04498936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Adding Sofosbuvir/Ledipasvir Combination, or Nitazoxanide to the Standard of Care in Treatment of COVID-19: A Randomized Controlled Trial
Lead sponsor
Assiut University
Phase
Phase 4
Overall status
Completed
Start date
July 15, 2020
Completion date
October 30, 2020
Enrollment
240 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid